Neurodegenerative diseases are a common cause of morbidity and cognitive impairment in
older adults. Most clinicians who care for the elderly are not trained to diagnose these …

Abstract Sixty years ago, Steele, Richardson and Olszewski designated progressive
supranuclear palsy (PSP) as a new clinicopathological entity in their seminal paper. Since …

Now in a thoroughly revised and updated Sixth Edition, Localization in Clinical Neurology is
cornerstone in clinical neurology. Designed to aid clinicians in their quest to locate the …

Background: Progressive supranuclear palsy (PSP) is a progressive hypokinetic rigid
disorder with supranuclear gaze palsy and frequent falls. Although clinical consensus …

Neuropsychiatric assessment of a patient with behavioral disorder is a complex and
multidimensional process which utilizes neurologic, psychological, and psychiatric …

Background: Balance impairment is a frequently encountered problem in patients with
Parkinson's disease. A profound balance disorder, however, is an atypical feature. Methods …

Progressive supranuclear palsy (PSP) is a neurodegenerative disease characterized
pathologically by 4 repeat tau deposition in various cell types and anatomical regions …

Background: Progressive supranuclear palsy (PSP) is the second most common cause of
parkinsonism after Parkinson's disease (PD). The classic syndrome of PSP is widely …

Recent research is leading to an ever-increasing range of investigative approaches whose
aim is to achieve effective neuroprotective or neurorestorative treatment for individuals …

In distinction to idiopathic Parkinson's disease (PD), the diagnosis of atypical Parkinson
syndromes comprises dementia with Lewy bodies (DLB), multiple system atrophy (MSA) …